Correspondingly, TP53-mutant tumours had a numerically higher but not statistically significant response rate than TP53 wild-type (WT) tumours (7 of 20, 35% versus 1 of 11, 9%, respectively; P = 0.20; Extended Data Fig. 3c). Here, TP53 is linked to neoplasm.